Annual report [Section 13 and 15(d), not S-K Item 405]

Income Taxes (Tables)

v3.25.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
Schedule of Income Tax Expense (Benefit)

The Company recorded the below income tax expense (benefit) attributable to income from continuing operations for the year ending December 31, 2024 and December 31, 2023 as follows:

 

 

 

December 31,

 

 

 

2024

2023

 

 

 

(In thousands, except percentages)

 

Current

 

 

 

 

 

 

Federal

 

$

(7

)

 

$

-

 

State

 

 

21

 

 

 

-

 

Foreign

 

 

(34

)

 

 

-

 

 

 

 

(20

)

 

 

-

 

Deferred

 

 

 

 

 

 

Federal

 

 

-

 

 

 

-

 

State

 

 

-

 

 

 

-

 

Foreign

 

 

-

 

 

 

-

 

 

 

 

-

 

 

 

-

 

Total income tax expense

 

$

(20

)

 

$

-

 

Schedule of Effective Income Tax Rate Reconciliation

The reconciliation of the provision computed at the federal statutory rate to the Company's provision (benefit) for income taxes as follows:

 

 

 

December 31,

 

 

 

2024

 

 

2023

 

 

 

(In thousands, except percentages)

 

Tax at federal statutory rate

 

$

(15,432

)

 

 

(21.0

)%

 

$

(28,354

)

 

 

(21.0

)%

State, net of federal benefit

 

 

12,779

 

 

 

17.4

%

 

 

(6,507

)

 

 

(4.8

)%

Stock based compensation

 

 

3,327

 

 

 

3.8

%

 

 

967

 

 

 

0.7

%

Fair value adjustments

 

 

(7,593

)

 

 

(9.6

)%

 

 

(3,555

)

 

 

(2.4

)%

Research and development credits

 

 

 

 

 

%

 

 

(1,121

)

 

 

(0.8

)%

Section 382 Limitation

 

 

14,583

 

 

 

19.8

%

 

 

 

 

 

 

Other

 

 

(745

)

 

 

(1.0

)%

 

 

675

 

 

 

0.2

%

Change in valuation allowance

 

 

(6,939

)

 

 

(9.4

)%

 

 

37,895

 

 

 

28.1

%

Total provision for income taxes

 

$

(20

)

 

 

%

 

$

 

 

 

%

Components of Deferred Tax Assets and Liabilities The components of deferred tax assets and liabilities are as follows:

 

 

 

December 31,

 

 

 

2024

 

 

2023

 

 

 

(In thousands)

 

Deferred tax assets

 

 

 

 

 

 

Net operating loss carryforwards

 

$

81,649

 

 

$

91,668

 

Research and development tax credits

 

 

5,086

 

 

 

12,087

 

Stock based compensation

 

 

5,866

 

 

 

6,162

 

Lease liability

 

 

2,632

 

 

 

3,098

 

Section 174 research and development capitalization

 

 

10,691

 

 

 

11,641

 

Interest expense

 

 

7,157

 

 

 

3,063

 

Other timing differences

 

 

8,754

 

 

 

1,408

 

Total deferred tax assets

 

$

121,835

 

 

$

129,127

 

Valuation allowance

 

$

(118,783

)

 

$

(125,722

)

Net deferred tax assets

 

$

3,052

 

 

$

3,405

 

 

 

 

 

 

 

Deferred tax liabilities

 

 

 

 

 

 

Fixed assets and intangibles

 

$

(299

)

 

$

(364

)

Right of use assets

 

$

(2,753

)

 

$

(3,041

)

Total deferred tax liabilities

 

$

(3,052

)

 

$

(3,405

)

Net deferred tax assets

 

$

 

 

$

 

Schedule of Unrecognized Tax Benefits Roll Forward

A reconciliation of the beginning and ending amount of gross unrecognized tax benefits is as follows:

 

 

 

December 31,

 

 

 

2024

 

 

2023

 

 

 

(In thousands)

 

Balance at beginning of year

 

$

6,060

 

 

$

4,750

 

Additions based on tax positions related to the current year

 

 

(3,301

)

 

 

1,310

 

Balance at end of year

 

$

2,759

 

 

$

6,060